These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25891095)

  • 1. Protein Flexibility in Drug Discovery: From Theory to Computation.
    Buonfiglio R; Recanatini M; Masetti M
    ChemMedChem; 2015 Jul; 10(7):1141-8. PubMed ID: 25891095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the challenges of protein flexibility in drug design.
    Antunes DA; Devaurs D; Kavraki LE
    Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein flexibility and ligand recognition: challenges for molecular modeling.
    Spyrakis F; BidonChanal A; Barril X; Luque FJ
    Curr Top Med Chem; 2011; 11(2):192-210. PubMed ID: 20939788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the role of receptor flexibility in structure-based drug discovery.
    Feixas F; Lindert S; Sinko W; McCammon JA
    Biophys Chem; 2014 Feb; 186():31-45. PubMed ID: 24332165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physics of biomolecular recognition and conformational dynamics.
    Chu WT; Yan Z; Chu X; Zheng X; Liu Z; Xu L; Zhang K; Wang J
    Rep Prog Phys; 2021 Dec; 84(12):. PubMed ID: 34753115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RosettaLigand docking with full ligand and receptor flexibility.
    Davis IW; Baker D
    J Mol Biol; 2009 Jan; 385(2):381-92. PubMed ID: 19041878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
    Good AC; Cheney DL
    J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.
    Gioia D; Bertazzo M; Recanatini M; Masetti M; Cavalli A
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29165360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for biomolecular structural recognition and docking allowing conformational flexibility.
    Sandak B; Nussinov R; Wolfson HJ
    J Comput Biol; 1998; 5(4):631-54. PubMed ID: 10072081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ensemble-based docking using biased molecular dynamics.
    Campbell AJ; Lamb ML; Joseph-McCarthy D
    J Chem Inf Model; 2014 Jul; 54(7):2127-38. PubMed ID: 24881672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scalable and accurate method for classifying protein-ligand binding geometries using a MapReduce approach.
    Estrada T; Zhang B; Cicotti P; Armen RS; Taufer M
    Comput Biol Med; 2012 Jul; 42(7):758-71. PubMed ID: 22658682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening.
    Sindhu T; Srinivasan P
    Mol Biosyst; 2015 May; 11(5):1305-18. PubMed ID: 25787676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of experimental and computational structural approaches in 7TM drug discovery.
    Topiol S; Sabio M
    Expert Opin Drug Discov; 2015 Oct; 10(10):1071-84. PubMed ID: 26211671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy assessment of protein-based docking programs against RNA targets.
    Li Y; Shen J; Sun X; Li W; Liu G; Tang Y
    J Chem Inf Model; 2010 Jun; 50(6):1134-46. PubMed ID: 20481574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accounting for induced-fit effects in docking: what is possible and what is not?
    Sotriffer CA
    Curr Top Med Chem; 2011; 11(2):179-91. PubMed ID: 20939789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational approach to de novo discovery of fragment binding for novel protein states.
    Konteatis ZD; Klon AE; Zou J; Meshkat S
    Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encompassing receptor flexibility in virtual screening using ensemble docking-based hybrid QSAR: discovery of novel phytochemicals for BACE1 inhibition.
    Chakraborty S; Ramachandran B; Basu S
    Mol Biosyst; 2014 Oct; 10(10):2684-92. PubMed ID: 25088750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.